Roberto Blanco Sequeiros, MD, PhD

Blanco Sequeiros is the chairman at the Medical Imaging Centre of Southwest Finland, Turku University Hospital. His research is centered on interventional radiology, particularly MRI. This has recently broadened to wider aspects of therapeutic, cellular and molecular research.

Kim Butts-Pauly, PhD

Alexandre Carpentier, MD, PhD

Carpentier is an academic neurosurgeon specialized in performing brain tumor and epilepsy surgery at the Pitie-Salpetriere University Hospital, Assistance Publique Hopitaux de Paris. He is Professor of Neurosurgery and Medicine at Paris 6 Sorbonne University School of Medicine in Paris France. His recent work focuses on ultrasound-based treatments developing a miniature interstitial ultrasound device for tumor ablation and an implantable ultrasound device for blood-brain barrier opening and drug delivery. Both are promoted by CARTHERA, a university spin-off company that he founded in 2010.

Charles Caskey, PhD

Caskey is an assistant professor at Vanderbilt University Medical Center where his laboratory focuses on therapeutic and diagnostic uses of ultrasound and multimodal image-guided therapy. He has worked on applications with ultrasound thermometry, MR-guided focused ultrasound, and ultrasound hyperthermia. 

Rajiv Chopra, PhD

Chopra is an Associate Professor in the Department of Radiology at the University of Texas Southwestern Medical Center, where he leads a research program in image-guided therapeutics. He has devoted his research career to the development of MR-HIFU systems and translation of the technology to humans. He has also explored the potential for localized drug delivery in the body using MR-HIFU and thermosensitive liposomes, and non-invasive opening of the blood-brain barrier. His interests include numerical modelling, device design and fabrication, preclinical testing of novel devices and techniques, and translation of HIFU into clinical evaluation.

Paul Fishman, MD, PhD

Fishman is Professor of Neurology, Pharmacology and Neurobiology at the University of Maryland School of Medicine, and Chief of Neurology for the VA Maryland Health Care System. With dual training in Neuroscience and Neurology his research interest is the translation of novel therapies for neurodegenerative diseases. He co-founded programs for Neurotoxin Therapeutics, Deep Brain Stimulation and is a founding member of FUS Center of Excellence at the University of Maryland. 

Wladyslaw Gedroyc, MBBS, MRCP, FRCR

Gedroyc is a consultant radiologist at St Mary’s Hospital Imperial College healthcare NHS trust London. He is an acknowledged pioneer in MR-guided focused ultrasound and image guided therapy having been working in the FUS field for more than 16 years. He is the author of multiple papers on focused ultrasound of fibroids, bone, facet joints, liver, brain and drug activation utilizing focused ultrasound. 

Chandan Guha, MBBS, PhD

Guha is the Vice Chair of Radiation Oncology at the Albert Einstein College of Medicine (Einstein) and Montefiore Medical Center and Professor of Pathology, Urology, and Radiation Oncology at Einstein. He is also the founding director of Einstein’s Institute for Onco-physics. Guha’s research work is in the fields of immunology, radiation oncology, and liver diseases. As a clinician, he is also involved in treating prostate and liver cancers.

Joo Ha Hwang, MD, PhD

Hwang is a Professor of Medicine at Stanford University. He specializes in early detection of gastrointestinal malignancies including esophageal cancer, gastric (stomach) cancer, pancreatic cancer, bile duct cancer and colon cancer. He has been performing research in the field of focused ultrasound since 2000, primarily investigating the use of FUS to enhance drug delivery for the treatment of pancreatic cancer. He is also the Principle Investigator of a new Foundation-organized multinational registry for focused ultrasound treatment of pancreatic cancer.

Tatiana Khokhlova, PhD

Khokhlova is a Research Assistant Professor at the Department of Medicine, University of Washington. Her research interests and expertise lie in physics of ultrasound wave propagation and the associated bioeffects, primarily in therapeutic applications of focused ultrasound. Khokhlova’s most recent work was targeted at the development of methods of soft tissue erosion and permeabilization by ultrasound-induced bubbles and the investigation of the resulting systemic effects, including immune response.

Elisa Konofagou, PhD

Konofagou is Professor of Biomedical Engineering and Radiology at Columbia University and head of the Ultrasound Elasticity Imaging Laboratory (UEIL) there. She is exploring alternative imaging techniques for focused ultrasound procedures, investigating neurological and cancer applications in preclinical studies, and working with her team to build medical devices in-house to meet their research needs.

Cyril Lafon, PhD

Lafon is a research director at INSERM and heads the LabTAU in Lyon. His early research included developing interstitial HIFU probes and ultrasound-induced hemostasis and the development of tissue mimicking phantoms for HIFU applications. His recent research interests focus on modeling ultrasound wave propagation, development of ultrasonic therapeutic devices for thermal ablation or drug delivery.

Nir Lipsman, MD, PhD, FRCSC

Lipsman is a neurosurgeon and scientist at Sunnybrook Research Institute and Sunnybrook Health Sciences Center, and an Assistant Professor in the Department of Surgery at the University of Toronto. His PhD investigated novel neuromodulation strategies for brain-circuit disorders, and he went on to complete a clinical fellowship in Stereotactic and Functional Neurosurgery. He is currently the clinical director for Sunnybrook’s Focused Ultrasound Center.  

Hao-Li Liu, PhD

Liu is the Professor and the Director of Department of Electrical Engineering, Chang-Gung University, Taoyuan, Taiwan, and also the Adjunct Assistant Researcher of Division of Medical Engineering Research, National Health Research Institutes, Miaoli, Taiwan. He is currently continuing research in ultrasound thermal therapy and its treatment planning/simulation, ultrasound-induced blood brain barrier (BBB) disruption for brain drug delivery, ultrasound phased array design. 

Nathan McDannold, PhD

McDannold is a Research Associate at Brigham and Women’s Hospital and an Associate Professor of Radiology at Harvard Medical School. His research has focused on brain applications, drug delivery and neurodegenerative diseases. A medical physicist, he has been a participant in the care of every focused ultrasound patient treated at BWH since 1996.

Franco Orsi, MD, PhD, EBIR

Orsi is the Chief of the Division of Interventional Radiology at the European Institue of Oncology. He leads a team of interventional radiologists using focused ultrasound to treat a variety of conditions, including cancers of the pancreas, liver, and breast. The Milan-based European Institute of Oncology treats a high volume of cancer patients with focused ultrasound each year, driving the rapid expansion of the technology in Europe.

Karun Sharma, MD

Sharma is the Director of Interventional Radiology at Children's National Health System. He was the principal investigator for a pediatric osteoid osteoma trial which began in 2015.

Gail ter Haar, PhD

ter Haar is the head of therapeutic ultrasound at the Institute of Cancer Research. Her research interests center on understanding how ultrasound interacts with tissue, especially the physical mechanisms involved in producing bio-effects (primarily heating & acoustic cavitation), and harnessing these effects for therapeutic benefit. Most recently her research has concentrated on developing devices and protocols for ultrasound based treatments of cancer.  She is founding President of the International Society for Therapy Ultrasound (ISTU).

Joan Vidal-Jove, MD, PhD

Vidal-Jove leads the first Oncological FUS-HIFU Unit in Spain at the Hospital University Mutua Terrassa. He is also Director of Interventional Oncology at the Institute Khuab in Barcelona. He has developed his career in various institutions in the U.S. and Europe, both in the healthcare field, research in the pharmaceutical industry and public administration. He has performed more than 200 oncological cases with focused ultrasound, including pancreatic and liver tumors.

Brad Wood, MD

Wood is the Director of the NIH Center for Interventional Oncology, where he directs a multi-disciplinary team that develops and translates devices, software, and navigation approaches for cancer patients via novel local and regional minimally-invasive image-guided therapies.

Zhen Xu, PhD

Xu is a tenured Associate Professor and Graduate Chair of the Department of Biomedical Engineering at the University of Michigan. Her research is focusing on ultrasound therapy, particularly the applications of histotripsy for noninvasive surgeries. 

Lian Zhang, MD

Zhang is the Co-director of Department of Oncology, the 2nd Affiliated Hospital of Chongqing Medical University and Secretary General of The International Society for Minimally-invasive and Non-invasive Medicine (ISMINIM). He is an expert in clinical application of HIFU technology with rich experience of working in many European HIFU centers.